Analyst Research

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

S&P Cuts Endo Health Solutions Inc Rating On Aggressive Financial Policies-DJ


Monday, 17 Jun 2013 03:04pm EDT 

Dow Jones reported that Standard & Poor's Ratings Services lowered its rating on Endo Health Solutions Inc. one notch further into junk territory, saying the pharmaceutical company has taken on more aggressive financial policies under its new leadership. S&P downgraded Endo's rating to double-B-minus, three notches into junk territory, from double-B. The outlook is stable. 

Company Quote

57.26
-0.44 -0.76%
17 Apr 2014